- CCC reported a preliminary EBITDA of 525 million zloty, surpassing the estimated 448.7 million zloty.
- Preliminary revenue for CCC reached 2.87 billion zloty, exceeding the forecasted 2.83 billion zloty.
- CCC’s preliminary EBIT amounted to 368 million zloty, outperforming the estimate of 287.7 million zloty.
- The company’s preliminary gross margin stood at 47.8%, slightly below the estimated 48.2%.
- Analyst recommendations for CCC include five buys, two holds, and three sells.
A look at CCC SA Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 1 | |
| Growth | 5 | |
| Resilience | 2 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 2.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Looking at CCC SA‘s long-term outlook through the lens of Smartkarma Smart Scores reveals a mixed picture. The company excels in Growth and Momentum, scoring a 5 and 4 respectively. This indicates a strong growth trajectory and positive market momentum. However, CCC SA falls short in terms of Dividend and Value, scoring a 1 and 2 respectively. This suggests that the company may not be as attractive to investors seeking stable dividend income or undervalued opportunities. In terms of Resilience, CCC SA scores a 2, indicating a moderate level of resilience to market fluctuations.
CCC S.A., a shoe manufacturer and retailer in Poland, shows promise in terms of Growth and Momentum, suggesting a positive outlook for the company’s expansion and market performance. However, the lower scores in Dividend and Value may give some investors pause. Overall, CCC SA‘s Smartkarma Smart Scores point to a company with strong growth potential and market momentum, albeit with some room for improvement in the areas of dividend yield and perceived value.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
